A rapid diagnostic test for the simultaneous detection of Toxoplasma, Rubella, Cytomegalovirus, and Herpes simplex IgG and IgM antibodies in serum or plasma samples.
Manufactured by
Canada
CITEST DIAGNOSTICS INC. is an emerging In-Vitro Diagnostics company founded in Canada by highly experienced IVD industry professionals with proven track records of building and growing successful companies. CITEST manufactures its IVD products in ISO13485:2016 accredited manufacturing facilities under strict quality control and regulatory compliance standards.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
AccuBioTech Co., Ltd.
China · 6 relevant products
InTec PRODUCTS, INC.
China · 4 relevant products
Hangzhou Frenovo Biotech Co., Ltd
China · 11 relevant products
Prometheus Bio Inc.
China · 1 relevant product
VEDALAB SAS
France · 5 relevant products
Hangzhou Tongzhou Biotechnology Co., Ltd.
China · 3 relevant products
Xiamen Biotime Biotechnology Co., Ltd.
China · 2 relevant products
Healgen Scientific LLC
United States · 1 relevant product
Atlas Link, Inc.
United States · 3 relevant products
EBD BIOTECH
Brazil · 1 relevant product
49 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 110 closest product alternatives
AccuBioTech Co., Ltd. · China
Multiplex rapid test for detection of toxoplasma, rubella, cytomegalovirus, and herpes simplex antibodies. Used in prenatal screening and infectious disease assessment.
InTec PRODUCTS, INC. · China
ELISA test kit for detection of toxoplasmosis, rubella, cytomegalovirus, and herpes simplex markers. Laboratory-based assay for congenital infection screening.
InTec PRODUCTS, INC. · China
Rapid immunochromatographic assay for qualitative detection of TORCH infection markers including toxoplasmosis, rubella, cytomegalovirus, and herpes simplex. Screening test for congenital infection assessment.
Hangzhou Frenovo Biotech Co., Ltd · China
Immunoglobulin-based rapid test for Toxoplasma gondii infection. Assists in diagnosis of toxoplasmosis in immunocompromised patients.
Hangzhou Frenovo Biotech Co., Ltd · China
A rapid diagnostic test for detecting TORCH infections (Toxoplasmosis, Rubella, Cytomegalovirus, and Herpes simplex virus). This test is suitable for preliminary screening in medical institutions.
Prometheus Bio Inc. · China
Rapid immunoassay for detecting toxoplasma-specific IgG and IgM antibodies in serum. Used for serological diagnosis of toxoplasmosis in pregnant women and immunocompromised patients.
VEDALAB SAS · France
Immunochromatographic rapid test for qualitative detection of IgG antibodies to Toxoplasma gondii in whole blood, plasma, or serum samples. Enables quick serological assessment for toxoplasmosis diagnosis in clinical settings.
Hangzhou Frenovo Biotech Co., Ltd · China
Immunoglobulin-based rapid test for rubella virus infection. Detects acute infection and immunity status for maternal and pediatric assessment.
Hangzhou Tongzhou Biotechnology Co., Ltd. · China
A comprehensive rapid test for rubella detection. This diagnostic test includes capability for procalcitonin (PCT) detection, providing comprehensive assessment in a single test.
Xiamen Biotime Biotechnology Co., Ltd. · China
Fluorescence immunoassay test for TORCH infections. Detects antibodies to toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus.
Healgen Scientific LLC · United States
Rapid immunochromatographic test for qualitative detection of COVID-19 IgG and IgM antibodies in serum, plasma, or whole blood samples. Delivers results in 10-15 minutes, enabling point-of-care screening and confirmation of SARS-CoV-2 infection. CLIA-waived format suitable for clinical laboratories and non-laboratory settings.
Atlas Link, Inc. · United States
Lateral-flow immunoassay for qualitative detection of IgG antibodies to Toxoplasma. Component of congenital infection screening protocols.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products